effects [qlco]
tibolone [phsu, strd]
Plasma homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
investigate [ftcn]
effects [qlco]
tibolone [phsu, strd]
Levels [qlco]
Plasma [bdsu]
homocysteine [aapp, bacs]
Independent [idcn]
Cardiovascular Disorders [dsyn]
postmenopausal [tmco]
Women [popg]
Design [acty]
prospective [resa]
randomized [resa]
Clinical Study [resa]
setting [ftcn]
university hospital [hcro, mnob]
postmenopausal [tmco]
Health [idcn]
Women [popg]
intervention [hlca]
tibolone [phsu, strd]
2 5 [qnco]
mg/d [qnco]
Calcium [bacs, elii, phsu]
mg/d [qnco]
Conjugated Equine Estrogens [horm, phsu, strd]
mg/d [qnco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg/d [qnco]
Administered [ftcn]
Orally [spco]
months [tmco]
blood samples [bdsu]
Collected [idcn]
Start [tmco]
End [spco]
therapy [ftcn]
Main [qlco]
outcome measure [qnco]
Plasma homocystine level [lbpr]
Administration [ocac]
tibolone [phsu, strd]
Calcium [bacs, elii, phsu]
Decrease [qlco]
Plasma homocystine level [lbpr]
Compared [acty]
Initial [tmco]
Levels [qlco]
Contrast [qlco]
Conjugated Equine Estrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Decrease [qlco]
Plasma homocystine level [lbpr]
Reported [inpr]
tibolone [phsu, strd]
serum lipid [lbpr]
Profile [lbpr]
tibolone [phsu, strd]
statistically significant [qnco]
Serum homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
CARDIOVASCULAR [bdsy]
tibolone [phsu, strd]
Unrelated [fndg]
effects [qlco]
homocysteine levels [lbpr]
